Table 5.
lncRNAs | Cancer type | Functions and phenotype | References |
---|---|---|---|
SLERT | Teratoma | Interacts with single DDX21 molecule to adjust the size of the DDX21 ring and relieve the inhibition of pol I, activates pol I -mediated transcription initiation directly and promote tumorgenesis. | [122] |
lncRNA AY | Hepatocellular carcinoma | Interacts with histone 1FX (H1FX) to the ITGAV promoter, enhances modification of H3K4Me3 and acH3K9/14 but reduces H3K27Me3 modification and H1FX occupation on ITGAV promoter. This causes a change of chromatin structure and pol II recruitment to target gene promoter for gene activation. | [125] |
NRCP | Ovarian cancer | Recruits both TF (STAT1) and RNA polymerase II as an intermediate to target gene’s promoter. The complex then increases the expression of downstream genes including glucose-6-phosphate isomerase to modulate cancer metabolism and promote ovarian cancer development. | [128] |